• Nenhum resultado encontrado

Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients.

N/A
N/A
Protected

Academic year: 2017

Share "Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients."

Copied!
11
0
0

Texto

Loading

Imagem

Table 1. Comparison of demographic and clinical characteristics between PD patients and HC.
Fig 1. Relative abundance of COPZ1 mRNA in the PPMI study. Relative abundance of COPZ1 in PD patients (black circles) compared to HC (white circles)
Table 2. Comparison of demographic and clinical characteristics of cognitively normal PD patients (PD-CN) and cognitively impaired PD patients (PD-MCI).
Fig 2. EFTUD2 and PTBP1 mRNAs as biomarkers for cognitive decline in PD. A. Relative abundance of EFTUD2 in PD patients with normal cognition (circles) compared to PD patients with mild cognitive impairment (triangles)

Referências

Documentos relacionados

studied some aspects of the validity of the MoCA for evaluating cognitive impairment in 66 Brazilian patients with PD, using the MDS-UPDRS, Hoehn-Yahr stage and MoCA test: 19.7 %

investigated the depressive symptoms of patients with Parkinson disease and mild cognitive impairment using several cognitive tests and the Beck..

Association of cerebrospinal fluid beta-amyloid 1-42, T-tau, P-tau181, and alpha-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.

Unified Parkinson’s Disease Rating Scale (UPDRS) part III (motor signs), part V (Hoehn and Yahr PD staging sca- le), part VI (Schwab and England daily activities scale) and

between the evaluation of body image (My Body Image test) and self-concept (Factorial Self-concept Scale) with the stage of the disease (Modiied Hoehn and Yahr Scale), the level

he patients underwent a series of clini- cal tests, including: Uniied Parkinson’s Disease Rating Scale, modiied Hoehn and Yahr Staging Scale, modiied Schwab and England

Two movement disorders spe- cialists performed the following scale: Unified Parkinson’s disease rating score (UPDRS), the modified Hoehn and Yahr staging, Schwab and England

M: Male; F: Female; PD: Parkinson´s Disease; HD: Huntington´s disease; TS: Tourette´s syndrome; SCA3: Spinocerebellar Ataxia type 3; HY: Hoehn&Yahr Scale; YGTSS: Yale